https://www.selleckchem.com/pr....oducts/Decitabine.ht
2; 95% CI, 1.3-30.4). WLWH from sub-Saharan Africa (SSA) had less 9-valent vaccine types, compared with both HIV-negative women born in Sweden (adjOR 0.1; 95% CI, 0.02-0.44) and WLWH born in Sweden (adjOR 0.1; 95% CI, 0.01-0.73), mostly because of decreased HPV16 and increased HPV35. WLWH from SSA were less likely to be covered by the 9-valent vaccine, mostly due to less HPV16 and more HPV35. This could have implications for HPV vaccines, currently not including HPV35, and for HPV-screening algorithms in women with origin from SSA. T
Like
Comment
Share
